MIR6877

Across TCGA pan-cancer cohorts, MIR6877 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR6877 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR6877 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6877 expression acts as an unfavorable survival marker, although some lineages such as BLCA and CESC show a favorable association.

KIRC, COAD, and ESCA are the cancer types where MIR6877 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.217	0.556	<.001	141	view →
COAD	OS	Tertile	III,IV	0.187	0.579	<.001	135	view →
ESCA	OS	Tertile	IV	0.143	0.668	.010	33	view →
BLCA	OS	Tertile	II,III,IV	0.759	0.593	.027	21	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
CESC	OS	Tertile	II,III,IV	0.943	0.459	.021	18	view →
LUAD	OS	Tertile	IV	0.153	0.714	.012	18	view →
PRAD	DFS	Tertile	All	0.776	0.894	.021	18	view →
READ	DFS	Tertile	IV	0.082	0.618	.012	18	view →
UCEC	OS	Tertile	IV	0.231	0.592	.036	18	view →
LUSC	DFS	Tertile	All	0.278	0.421	.023	15	view →
ACC	OS	Tertile	III,IV	0.162	0.467	.029	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR6877–KIRC (OS)

Open the KIRC breakdown →